Reduction of Erythema in Moderate-Severe Rosacea by a Low Molecular Weight Heparan Sulfate Analog (HSA).
George R, Gallo RL, Cohen JL, Brown M, Okeke CAV, Byrd AS.
George R, et al. Among authors: gallo rl.
J Drugs Dermatol. 2023 Jun 1;22(6):546-553. doi: 10.36849/JDD.7494.
J Drugs Dermatol. 2023.
PMID: 37276169
Clinical Trial.
These findings support the use of DRC in rosacea topical treatment regimens as it demonstrates visible skin benefits and improves tolerability of PDL therapy in a shorter duration of time as compared with PDL alone.George R, Gallo RL, Cohen JL, et al. Reduction of e …
These findings support the use of DRC in rosacea topical treatment regimens as it demonstrates visible skin benefits and improves tolerabili …